• Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 07 Nov 2024 02:32:16   America/New_York


    Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Editas Medicine, Inc. ( NASDAQ:EDIT - Get Free Report ) has earned
    Read more...
Share on,